Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SLFN11-positive”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT06217757
What this trial is testing

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung Cancer
Sichuan University 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT04334941
What this trial is testing

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Looking for participantsNCT05718323
What this trial is testing

Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC

Who this might be right for
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation 44
Testing effectiveness (Phase 2)Study completedNCT04939662
What this trial is testing

Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects

Who this might be right for
Lung Cancer
Se-Hoon Lee 25

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation